Blog

Monday, October 6, 2025It’s tough doing business in an environment of no compromise. We’d already seen evidence of this in difficult negotiations with some of our country’s biggest trading partners

Franklin Resources, Inc. BEN reported its preliminary assets under management (AUM) of $1.66 trillion as of Sept. 30, 2025, which increased nearly 1% from the prior month.

The increase in the AUM

Marvell Technology MRVL has climbed 30.6% in a month, outperforming the Zacks Electronics - Semiconductors industry’s return of 4.4%. This sharp rise in the share price of this semiconductor leader

Opendoor Technologies Inc. OPEN is undergoing a major business transformation, moving from a pure-play iBuyer to a distributed platform that relies more heavily on agents and diversified offerings

As global data creation accelerates, driven by AI, cloud computing, video content, and edge applications, demand for scalable, high-performance, and cost-efficient storage solutions is surging. The

In a world that’s rapidly embracing digital change, Mastercard Incorporated MA is stepping up its game, transforming from a traditional card network into a powerhouse of predictive intelligence. By

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, October 6th:

Pagaya Technologies Ltd. PGY: This product-focused technology company has a

Simon Property Group’s SPG multi-billion-dollar investments aimed at premium acquisitions and transformative redevelopments are instrumental in driving cash flow and the future growth story. The

Build-A-Bear Workshop, Inc.’s BBW second-quarter fiscal 2025 results offered an insight into how its e-commerce operation is becoming a growth lever. The company reported a 15.1% rise in

Centrus Energy LEU remains fundamentally strong, supported by the favorable long-term outlook for uranium and its strategic investments in increasing production. It is positioning itself to become a

Dutch Bros Inc. BROS is focusing on the targeted expansion of its food pilot program to capture the untapped potential in the high-frequency morning daypart. The company, best known for its

Esperion Therapeutics ESPR announced that it has entered into a settlement agreement with Dr. Reddy’s Laboratories RDY related to patents for the marketed drugs, Nexletol (bempedoic acid) and

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The research service

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The popular research

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

Featuring daily updates

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.

The research service

Shares of Genmab A/S GMAB have rallied 21.9% in a month. The stock price rally was observed after the company signed a definitive agreement in late September to acquire Merus N.V. MRUS for $97 per

Stocks hitting their 52-week high and delivering consistent performance offer attractive opportunities to investors while building a portfolio. This is because stocks near that level are perceived

For Immediate Release

Chicago, IL – October 6, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and